An active microbiological surveillance project at an Italian teaching Hospital: Microbial isolates, recent epidemiological trends, major clinical concerns, and antimicrobial susceptibility rates during a four-year period

Infezioni in Medicina

Volumn 17, Issue 4, 2009, Pages 219-227

  Manfredi, Roberto ^a   Nanetti, Anna ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antimicrobial susceptibility; Epidemiology; Microbiological surveillance

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOOD CULTURE; ENTEROBACTERIACEAE; ENTEROCOCCUS; ESCHERICHIA COLI; HUMAN; ITALY; NONHUMAN; PSEUDOMONAS AERUGINOSA; SENSITIVITY ANALYSIS; SEPSIS; STAPHYLOCOCCUS AUREUS; TEACHING HOSPITAL; URINARY TRACT INFECTION;

BACTEREMIA; DATA INTERPRETATION, STATISTICAL; DRUG RESISTANCE, MICROBIAL; FUNGI; HOSPITALS, TEACHING; HUMANS; ITALY; MICROBIAL SENSITIVITY TESTS; MICROBIOLOGY; SEPSIS; TIME FACTORS;

EID: 77649247156     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Nordmann P., Naas T., Fortineau N., Poirel L. Superbugs in the coming new decade: multidrug resistance and prospects for treatment of Staphylococcus aures, Enterococcus spp., and Pseudomonas aeruginosa in 2010. Curr. Opin. Microbiol. 10: 436-440, 2007.
2. Macgowan A.P. BSAC Working Parties on Resistance Surveillance. Clinical implications of antimicrobial resistance for therapy. J. Antimicrob. Chemother. 62 (Suppl. 2): ii105-ii114, 2008.
3. Marcel J, Alfa M, Baquero F, et al. Healthcare-associated infections: think globally, act locally. Clin. Microbiol. Infect. 14: 895-507, 2008.
4. Masterton R. The importance and future of antimicrobial surveillance studies. Clin. Infect. Dis. 47 (Suppl. 1): S21-S31, 2008.
5. Hawkey P.M. The growing burden of antimicrobial resistance. J. Antimicrob. Chemother. 62 (Suppl. 1): i1-i9, 2008.
6. Casey A.L., Mermel L.A., Nightingale P., Elliott T.S. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect. Dis. 8: 763-776, 2008.
7. Maragakis L.L., Perencevich E.N., Cosgrove S.E. Clinical and economic burden of antimicrobial resistance. Expert Rev. Anti Infect. Ther. 6: 751-763, 2008.
8. Clinical and Laboratory Standards for Antimicrobial Susceptibility Testing (AST), 2008. Clinical Laboratory Standards Isntitute (CLSI). Aggiornamenti disponibili su web all'indirizzo: www.clsi.org
9. Stefani S., Varaldo P.E. Epidemiology of methicillin-resistant staphylococci in Europe. Clin. Microbiol. Infect. 9: 1179-1186, 2003.
10. Johansen T.E., Cek M., Naber KG, et al. Hospital acquired urinary tract infections in Urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP study. Int. J. Antimicrobial Agents. 28 (Suppl. 1): S91-S107, 2007.
11. Schonheyder H.C., Sogaard M. Hospital-acquired bacteraemia and fungaemia. A regional study with national implications. Ugeskr. Laeger. 169: 4175-4179, 2007.
12. Esposito S., Fiore M. Use of fluoroquinolones in intensive care units in a multi-drug-resistant era. Infez. Med. 15, 159-168, 2007.
13. Pérez-González L.F., Ruiz-González J.M., Noyola D.E. Nosocomial bacteremia in children: a 15-year experience at a general Hospital in Mexico. Infect. Control Hosp. Epidemiol. 28: 418-422, 2007.
14. Viale P., Stefani S. Vascular catheter-associated infections: a microbiological and therapeutic update. J. Chemother. 18: 235-249, 2006.
15. Zingg W., Cartier-Fässler V., Walder B. Central venous catheter-associated infections. Best Pract. Res. Clin. Anesthesiol. 22: 407-421, 2008.
16. Esposito S., Noviello S., Leone S. Catheter-associated urinary tract infections: epidemiology and prevention. Infez. Med. 16: 130-143, 2008.
17. Woodford H.J., George J. Diagnosis and management of urinary tract infection in hospitalized older people. J. Am. Geriatr. Soc. 2008 (Nov. 14) [Epub ahead of print], 2008.
18. Lichtenberger P., Hooton T.M. Complicated urinary tract infections. Curr. Infect. Dis. Rep. 10: 499-504, 2008.
19. Moreillon P. New and emerging treatment of Staphylococcus aureus infections in the hospital setting. Clin. Microbiol. Infect. 14 (Suppl. 3): 32-41, 2008.
20. Falagas M.E., Kopterides P. Old antibiotics for infections in critically ill patients. Curr. Opin. Crit. Care. 13: 592-597, 2007.
21. Arias C.A., Murray B.E. Emergence and management of drug-resistant enterococcal infections. Expert Rev. Anti Infect. Ther. 6: 637-655, 2008.
22. Cornaglia G., Akova M., Amicosante G., et al. Metallo-beta-lactamases as emerging resistance determinants in Gram negative pathogens: open issues. Int. J. Antimicrob. Agents. 29: 380-388, 2007.
23. Pitout J.D., Laupland K.B. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public health concern. Lancet Infect. Dis. 8: 159-166, 2008.
24. Bassetti M., Repetto E. Diagnostic and therapeutic management of Gram negative infections. Infez. Med. 16 (Suppl. 2): 22-29, 2008.
25. Bassetti M., Righi E., Viscoli C. Pseudomonas aeruginosa serious infections: mono or combination antimicrobial therapy? Curr. Med. Chem. 15: 517-520, 2008.
26. Rodríguez-Ba o J., Pascual A. Clinical significance of extended-spectrum beta-lactamases. Expert Rev. Anti Infect. Ther. 6: 671-683, 2008.
27. Gilad J., Carmeli Y. Treatment options for multidrug-resistant Acinetobacter species. Drugs 68: 165-189, 2008.
28. Bassetti M., Repetto E., Righi E., et al. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumanii infections. J. Antimicrob. Chemother. 61: 417-420, 2008.